Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-065653

Jazz Pharmaceuticals plc · JAZZ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Bruce C Cozadd
Officer — Chairman and CEO · Director
Period of report
Aug 10, 2015
Accepted (ET)
Aug 12, 2015 · 5:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF2,F3Aug 10, 2015F7,743$181.48D299,355D
Ordinary SharesAug 11, 2015S2,500$177.82D296,855D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Incentive Stock Option (right to buy)F6$11.48Aug 7, 2015J6,896D—Mar 7, 2020Ordinary Shares6,8966,895D
Incentive Stock Option (right to buy)F7$46.83Aug 7, 2015J1,618D—Aug 8, 2022Ordinary Shares1,6182,652D
Non-Qualified Stock Option (right to buy)F8$46.83Aug 7, 2015J89,098D—Aug 8, 2022Ordinary Shares89,098106,632D
Incentive Stock Option (right to buy)F9$59.13Aug 7, 2015J403D—Mar 4, 2023Ordinary Shares4031,288D
Non-Qualified Stock Option (right to buy)F10$59.13Aug 7, 2015J50,636D—Mar 4, 2023Ordinary Shares50,63672,673D
Incentive Stock Option (right to buy)F11$166.62Aug 7, 2015J67D—Feb 26, 2024Ordinary Shares67533D
Non-Qualified Stock Option (right to buy)F12$166.62Aug 7, 2015J17,149D—Feb 26, 2024Ordinary Shares17,14948,251D

Explanation of responses